|
Nov 9
|
Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Nov 9
|
Midday movers: Walt Disney, Lyft, Tesla and more
|
|
Nov 9
|
Father with brain injury sues pharma giant over Covid vaccine ‘defect’
|
|
Nov 6
|
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
|
|
Nov 6
|
Pharma Stocks Are Bleeding. But These 2 Look Like Bargains.
|
|
Nov 6
|
Unlocking Q3 Potential of Astrazeneca (AZN): Exploring Wall Street Estimates for Key Metrics
|
|
Nov 5
|
12 Best Large Cap Stocks To Buy Now
|
|
Nov 3
|
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
|
|
Nov 3
|
Q3 2023 Ionis Pharmaceuticals Inc Earnings Call
|
|
Nov 2
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Nov 1
|
Health Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
|
|
Oct 31
|
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
|
|
Oct 3
|
The 10 pharma companies participating in Medicare price negotiations
|
|
Oct 3
|
AstraZeneca pays £350m to settle heartburn drugs lawsuits
|
|
Oct 3
|
AstraZeneca settles heartburn drug lawsuits for $425mn
|
|
Oct 3
|
UPDATE 3-AstraZeneca to pay $425 million to end US lawsuits over heartburn drugs
|
|
Oct 3
|
AstraZeneca to pay $425 million to end US lawsuits over heartburn drugs
|
|
Oct 2
|
J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study
|
|
Oct 2
|
AstraZeneca (AZN) Key Drugs to Aid Growth, Pipeline Strong
|
|
Sep 30
|
20 Best Residency by Investment Programs in 2023
|